1. Novel quinazoline-based EGFR kinase inhibitors: A review focussing on SAR and molecular docking studies (2015-2019)
2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
3. The epidermal growth factor receptor (EGRF) in lung cancer
4. Case, D. A., Aktulga, H. M., Belfon, K., Ben-Shalom, I. Y., Brozell, S. R., Cerutti, D. S., Cheatham, T. E., III, Cisneros, G. A., Cruzeiro, V. W. D., Darden, T. A., Duke, R. E., Giambasu, G., Gilson, M. K., Gohlke, H., Goetz, A. W., Harris, R., Izadi, S., Izmailov, S. A., Jin, C., … Kollman, P. A. (2021). Amber 2021. University of California.
5. Mechanisms of receptor tyrosine kinase activation in cancer